Skip to main content
Clinical Trials/NCT06765278
NCT06765278
Recruiting
Not Applicable

Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group (PENG) Block Versus Interscalene Brachial Plexus (ISB) Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

Ain Shams University1 site in 1 country49 target enrollmentJanuary 13, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Glenoid Nerve Block
Sponsor
Ain Shams University
Enrollment
49
Locations
1
Primary Endpoint
Time to the 1st rescue analgesia
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

Detailed Description

Major surgeries of the shoulder constitute some of the most commonly performed orthopedic procedures. They often result in moderate to severe postoperative pain thereby requiring a multimodal analgesic approach centered around peripheral nerve blocks. Postoperative pain management is the part of shoulder surgery to improve patient satisfaction, start rehabilitation process rapidly and decrease for hospital stay. Interscalene blocks (ISB) are well-studied and established means of providing analgesia following shoulder surgery and are considered the gold standard mode of regional anesthesia and post-operative pain management in shoulder surgeries. A novel technique: pericapsular nerve group (PENG) block can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. In addition, PENG block targets articular branches with less motor effect compared with interscalene brachial plexus block providing anesthetic and analgesic effect with less complication and better and sooner ambulation.

Registry
clinicaltrials.gov
Start Date
January 13, 2025
End Date
June 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Serry

Assistant Lecturer of Anaesthesia, Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Ain Shams University

Eligibility Criteria

Inclusion Criteria

  • Age from 18 to 70 years.
  • No sex predilection.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Undergoing shoulder arthroscopic surgeries.

Exclusion Criteria

  • Patient's refusal.
  • Patients with a history of drug allergies to study drugs.
  • Evidence of local infection at the site of injection.
  • Inability to cooperate
  • Neuromuscular pathology (example: - Multiple Sclerosis)
  • Previous trauma or surgery to the shoulder

Outcomes

Primary Outcomes

Time to the 1st rescue analgesia

Time Frame: 24 hours postoperatively

Time to the first request for the rescue analgesia (time from the end of surgery to the first dose of pethidine administrated).

Secondary Outcomes

  • Total pethidine consumption(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)
  • Length of hospital stay(Till discharge from hospital (Up to one week).)
  • Time needed for the patient to freely move the operated limb(Postoperatively (Up to one week).)
  • Degree of patients satisfaction(24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials